Home  
  Our Team  
  Patient Info  
  Services  
   
  Pay My Bill  
  Contact Us  

News for Healthier Living

Tackling cancer from the inside out: a deep dive into immune checkpoint inhibitors

In the past two decades, immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, showing promising results against various solid tumors. This study reviews recent developments in ICIs, focusing on new targets like T cell immunoreceptor with Ig and ITIM domains (TIGIT), T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3), and lymphocyte activation gene-3 (LAG-3). These targets aim to overcome resistance mechanisms limiting the effectiveness of current therapies, such as anti-PD-1 and anti-CTLA-4. By identifying and developing these new ICIs, researchers hope to improve treatment outcomes and provide new therapeutic options for cancer patients.

August 13, 2024


August 23 2024

August 22 2024

August 21 2024

August 20 2024

August 19 2024

August 18 2024

August 17 2024

August 16 2024

August 15 2024

August 14 2024

August 13 2024

August 12 2024

August 11 2024

August 10 2024

August 9 2024